Teva Pharma Gets Approval to Market Generic Nasal Spray for Opioid Overdoses - WSJ
Teva Pharmaceuticals USA - News, Articles etc. - European Pharmaceutical Review
Teva sells Overland Park business segment - Kansas City Business Journal
TEVA News Today | Why did Teva Pharmaceutical Industries stock go down today?
Do Analysts Expect Teva Pharmaceutical Industries Ltd (TEVA) Stock to Rise After It Has Gained 10.21% in a Month?
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceutical Industries Adds US$389m To Market Cap, But Investors Still Down 47% From Five Years Ago - Simply Wall St News
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceutical Industries (TEVA) Analysts Prediction, Stock Forecast & Price Targets - Simply Wall St
teva News and latest stories | The Jerusalem Post
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace
Teva Pharmaceuticals unchanged before hours on Q1 earnings beat - MassDevice
Teva Pharmaceutical Stock Could Double | Barron's
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceutical Industries Ltd. | Global Philadelphia Association
